Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Hillstream BioPharma Inc.

    NASDAQ: HILS · Real-Time Price · USD
    0.24
    0.02 (7.00%)
    At close: Sep 22, 2023, 9:59 PM

    Hillstream BioPharma Statistics

    Share Statistics

    Hillstream BioPharma has 17.6M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 17.6M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 11.46M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,782

    FTD / Avg. Volume

    n/a
    		 0.41%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.03 and the forward PE ratio is null. Hillstream BioPharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.03

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.03

    P/FCF Ratio

    n/a
    		 -0.03

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Hillstream BioPharma has an Enterprise Value (EV) of -10.7M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 1.13

    EV / EBIT

    n/a
    		 1.47

    EV / FCF

    n/a
    		 1.47

    Financial Position

    The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.03

    Quick Ratio

    n/a
    		 6.03

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 572.87

    Financial Efficiency

    Return on Equity is -102.06% and Return on Invested Capital is -103.55%.

    Return on Equity

    n/a
    		 -102.06%

    Return on Assets

    n/a
    		 -85.13%

    Return on Invested Capital

    n/a
    		 -103.55%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-9,319,094

    Employee Count

    n/a
    		 1

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 32.6% in the last 52 weeks. The beta is 0, so Hillstream BioPharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 32.6%

    50-Day Moving Average

    n/a
    		 0.22

    200-Day Moving Average

    n/a
    		 0.56

    Relative Strength Index (RSI)

    n/a
    		 41.23

    Average Volume (20 Days)

    n/a
    		 684,778

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -9.46M

    Net Income

    n/a
    		 -9.32M

    EBITDA

    n/a
    		 -9.46M

    EBIT

    n/a
    		 -9.34M

    Earnings Per Share (EPS)

    n/a
    		 -7.14
    Full Income Statement

    Balance Sheet

    The company has 10.94M in cash and 0 in debt, giving a net cash position of 10.94M.

    Cash & Cash Equivalents

    n/a
    		 10.94M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -24.7M

    Total Assets

    n/a
    		 3.17M

    Working Capital

    n/a
    		 1.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.3M and capital expenditures 0, giving a free cash flow of -7.3M.

    Operating Cash Flow

    n/a
    		 -7.3M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -7.3M

    FCF Per Share

    n/a
    		 -5.59
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    HILS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -3944.02%

    FCF Yield

    n/a
    		 -3089.55%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HILS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -14.81

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist